Lifecome Biochemistry Co (002868.SZ) Stock Price

Lifecome Biochemistry Co., Ltd. generates revenue through the production and sale of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives, and biological pesticides. The company's product portfolio includes bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series, and Jinggangmycin series. These products are distributed domestically and internationally, targeting agricultural and veterinary sectors for animal health and feed enhancement. The firm's primary customers are domestic agricultural enterprises and international buyers seeking veterinary and feed solutions. Veterinary premixes and raw materials are key revenue drivers, alongside biological pesticides used in farming. Food and feed additives cater to the growing demand for safe and efficient animal nutrition products in both local and global markets. Lifecome Biochemistry's sales strategy focuses on leveraging its range of microbial pharmaceuticals, including probiotics and biological pesticides, to serve the agricultural industry. The company's domestic market presence is complemented by overseas distribution, ensuring a steady revenue stream from both regional and international clients.